Matthew Donley
Equibles does not estimate personal net worth.
Get an email with a short summary when Aurinia Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.
Get AUPH alertsAbout Matthew Donley
Matthew Donley is recorded as COO at Aurinia Pharmaceuticals Inc. (AUPH). The newest filing on record that lists Matthew Donley as COO at Aurinia Pharmaceuticals Inc. (AUPH) is dated April 21, 2026. The proxy statement of Aurinia Pharmaceuticals Inc. reports total compensation of $2,237,088 for Matthew Donley in fiscal 2025, including a base salary of $567,636. Disclosed compensation is on record for 3 fiscal years. Aurinia Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aurinia Pharmaceuticals Inc. includes Jeffrey Bailey (CEO and Board Member), Kevin Tang (CEO and Board Member), Peter Greenleaf (CEO and Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 21, 2026
Company network
Leadership on record at Aurinia Pharmaceuticals Inc.
- Jeffrey Bailey CEO, Board Member
- Kevin Tang CEO, Board Member
- Peter Greenleaf CEO, Board Member
- Joseph Miller CFO
- Michael Hearne CFO
- Ryan Cole COO
- Stephen Robertson General Counsel
- Craig Johnson Board Member
- Dr. Karen Smith Board Member
- Dr. Robert T. Foster Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Operating Officer | $567,636 | $2,237,088 |
| 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Operating Officer | $539,321 | $2,514,527 |
| 2023 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Operating Officer | $513,640 | $4,558,086 |
Recent activity
No call appearances or filed executive changes recorded yet.